The use of intravenous immunoglobulin in sine causa or alloimmune recurrent spontaneous abortion (RSA)

Citation
A. Patriarca et al., The use of intravenous immunoglobulin in sine causa or alloimmune recurrent spontaneous abortion (RSA), PANMIN MED, 42(3), 2000, pp. 193-195
Citations number
17
Categorie Soggetti
General & Internal Medicine
Journal title
PANMINERVA MEDICA
ISSN journal
00310808 → ACNP
Volume
42
Issue
3
Year of publication
2000
Pages
193 - 195
Database
ISI
SICI code
0031-0808(200009)42:3<193:TUOIII>2.0.ZU;2-U
Abstract
Background. Recurrent spontaneous abortion (RSA) has an incidence of 0.5 % -1 %, It is thought that immune reaction disorders in the mother may evolve in unexplained RSA, which has a higher incidence In women over 40 years ol d. Methods. Twenty-three patients with recurrent spontaneous abortion of unkno wn origin and two autoimmune cases were treated with intravenous specific i mmunoglobulins at the 5th-6th week of pregnancy and fifteen days later. Results, After treatment, nineteen patients brought their pregnancy to term , five aborted, one is pregnant at present. Conclusions. The use of immunoglobulins seems to be efficacious in recurren t spontaneous abortion of unknown origin. Our results support the theory th at this treatment is able to passively transfer the sparking off factor tha t allows the pregnancy to evolve.